(Q33337565)

English

Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Adaptive radiation therapy

0 references

Aleksandar Dagovic

1 reference

ORCID Public Data File 2021

author name string

Jeremic B

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Shibamoto Y

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Grujicic D

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Stojanovic M

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Milicic B

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Nikolic N

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dagovic A

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Aleksandrovic J

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

133-141

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

https://scigraph.springernature.com/pub.10.1023/a:1010621400203

0 references

Etoposide (VP-16-213) in malignant brain tumors: a phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bradykinin selectively opens blood-tumor barrier in experimental brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The interaction of etoposide with radiation: variation in cytotoxicity with the sequence of treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of accelerated hyperfractionated radiotherapy and conventional radiotherapy for supratentorial malignant glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated fractionation for high-grade cerebral astrocytomas. Preliminary treatment results

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting chemotherapy for malignant brain tumor using thermosensitive liposome and localized hyperthermia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell kinetic analyses of human malignant brain tumors (gliomas)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous hyperfractionated accelerated radiotherapy in the treatment of high-grade astrocytomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifocal enhancing magnetic resonance imaging lesions following cranial irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advantage of Post-Radiotherapy Chemotherapy with CCNU, Procarbazine, and Vincristine (mPCV) Over Chemotherapy with VM-26 and CCNU for Malignant Gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accelerated hyperfractionated radiotherapy for malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early chemotherapy and concurrent radio-chemotherapy in high grade glioma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modifying radical radiotherapy in high grade gliomas; shortening the treatment time through acceleration.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I Study of Intracarotid Administration of Carboplatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic irradiation and brain injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic basis for altered fractionation schemes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sample size considerations for studies comparing survival curves using historical controls

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11386410

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1010621400203

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33337565&oldid=1583806471"